Heartland Financial USA Azioni (NASDAQ: HTLF)

Ultime notizie per Heartland Financial USA (NASDAQ:HTLF) Azioni

Heartland Financial USA

Heartland Financial USA Inc is a multi-bank holding company that offers a wide range of commercial, small business, and consumer banking services to businesses, including public sector and non-profit entities and individuals. It also provides traditional and non-traditional service channels including online banking, mobile and remote banking, and telephone banking. The company's business lines are Commercial Banking, Agricultural Loans, Small Business Banking, Residential Real Estate Mortgage Lending, Consumer Banking, and Wealth Management and Retirement Plan Services.

Heartland Financial USA, Inc. - Common Stock

Heartland Financial USA Inc

Heartland Financial USA, Inc. - Depositary Shares, each representing a 1/400th ownership interest in a share of 7.00% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E

WIIM

ABCB

ACNB

AMAL

AMTB

AROW

BANF

BANR

BCAL

BFST

BHLB

BHRB

BMRC

BOKF

BPOP

BRKL

BSRR

BSVN

BUSE

CARE

CASH

CATY

CBAN

CBNK

CBSH

CCBG

CCNE

CFFN

CHCO

CLBK

CNOB

COFS

CTBI

CUBI

CVBF

CZFS

DCOM

EBTC

EFSC

EGBN

EQBK

EWBC

FBIZ

FBMS

FBNC

FCBC

FCNCA

FFBC

FFIC

FFIN

FFWM

FIBK

FISI

FLIC

FMAO

FMBH

FMNB

FNLC

FRBA

FRME

FRST

FSBC

GABC

GBCI

GCBC

GNTY

GSBC

HAFC

HBCP

HBNC

HFBL

HFWA

HIFS

HMST

HOMB

HONE

HOPE

HTBI

HTBK

HTLF

Shares of banking-related companies are trading higher after Donald Trump won the US presidential election.

Heartland Financial USA shares are trading higher. The company reported Q3 financial results.

Heartland Financial USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) reported quarterly earnings of $1.17 per share which met the analyst consensus estimate. This is a 8.33 percent increase over earnings of $1.08 per share from the same period last year.

Earnings

News

Heartland Financial USA Q3 Adj $1.17, Inline

Heartland Financial USA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NYSE">HTLF</a>) short percent of float has risen 42.41% since its last report. The company recently reported that it has 986 thousand shares sold short, which is 2.72% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.1 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Heartland Financial USA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726155021_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Heartland Financial USA has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Heartland Financial USA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Heartland Financial USA's peer group average for short interest as a percentage of float is 5.30%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Is The Market Feeling About Heartland Financial USA?

BANC

BBDO

FULT

IBTX

INDB

KRNY

MOFG

NBTB

NYCB

PPBI

RBCAA

SBCF

SFBS

SFNC

TCBI

TRMK

UMBF

WSFS

Shares of banking companies are trading higher amid overall market strength following Fed Chair Powell's comments about the economy and future rate cuts.

Heartland Financial USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.14 by 0.88 percent. This is a 3.6 percent increase over earnings of $1.11 per share from the same period last year.

Earnings Beats

Heartland Financial USA Q2 Adj $1.15 Beats $1.14 Estimate

As of July 15, 2024, five stocks in the financials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Root Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>)</h3>
<ul>
<li>On June 5, TD Cowen analyst Andrew Kligerman maintained Root with a Hold and raised the price target from $11 to $51. The company's stock gained around 57% over the past month and has a <a href="https://www.benzinga.com/quote/ROOT">52-week high of $86.57</a>.</li>
<li>RSI Value: 71.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ROOT Price Action: Shares of Root gained 9.7% to close at $69.41 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Bank of New York Mellon Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>)</h3>
<ul>
<li>On July 12, the finance behemoth reported second-quarter adjusted earnings per share of $1.51, beating the street view of $1.43. "Halfway through the year, we're pleased with the progress we have made, but we are focused on running our company better and the hard work ahead. As highlighted in our improved financial performance to-date, we are starting to demonstrate the power of BNY's franchise to our clients and shareholders, and we remain in execution mode to unlock the company's full potential," said Robin Vince, President and Chief Executive Officer. The company's stock gained around 7% over the past five days and <a href="https://www.benzinga.com/quote/BK">has a 52-week high</a> of $64.92.</li>
<li>RSI Value: 77.99</li>
<li>BK Price Action: Shares of Bank of New York Mellon gained 5.2% to close at $64.69 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Credit Acceptance Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CACC#NASDAQ">CACC</a>)</h3>
<ul>
<li>On June 20, Credit Acceptance announced the completion of $550.0 million asset-backed financing. The company's stock gained around 21% over the past month and has a <a href="https://www.benzinga.com/quote/CACC">52-week high </a> of $616.66.</li>
<li>RSI Value: 82.70</li>
<li>CACC Price Action: Shares of Credit Acceptance gained 2.9% to close at $576.77 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Northern Trust Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>)</h3>
<ul>
<li>On July 2, Goldman Sachs analyst Alexander Blostein maintained Northern Trust with a Neutral and lowered the price target from $94 to $84. The company's stock jumped around 7% over the past five days and has a 52-week high of $89.73.</li>
<li>RSI Value: 70.43</li>
<li>NTRS Price Action: Shares of Northern Trust gained 2.8% to close at $89.28 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Heartland Financial USA Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>)</h3>
<ul>
<li>On May 31, Keefe, Bruyette &amp; Woods analyst Damon Delmonte upgraded Heartland Financial from Market Perform to Outperform and raised the price target from $51 to $54. The company's stock jumped around 10% over the past five days and <a href="https://www.benzinga.com/quote/HTLF">has a 52-week high</a> of $48.57.</li>
<li>RSI Value: 72.40</li>
<li>HTLF Price Action: Shares of Heartland Financial gained 1.2% to close at $48.17 on Friday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39748049/how-to-earn-500-a-month-from-bank-of-america-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Bank of America Stock Ahead Of Q2 Earnings</a></li>
</ul>

Pre-Market Outlook

Markets

CACC

NTRS

ROOT

Top 5 Financials Stocks That May Collapse This Month

Heartland Financial USA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NYSE">HTLF</a>) short percent of float has risen 12.83% since its last report. The company recently reported that it has 918 thousand shares sold short, which is 2.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.76 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Heartland Financial USA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720802716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Heartland Financial USA has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Heartland Financial USA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Heartland Financial USA's peer group average for short interest as a percentage of float is 5.62%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Heartland Financial USA's Recent Short Interest

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Brent Bracelin upgraded the rating for Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) from Underweight to Neutral, but slashed the price target from $18 to $16. Asana shares fell 4.9% to close at $13.13 on Thursday. <a href="https://www.benzinga.com/quote/ASAN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler analyst Stephen Scouten upgraded Independent Bank Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBTX#NASDAQ">IBTX</a>) from Underweight to Overweight, while raising the price target from $38 to $58. Independent Bank shares rose 2.4% to settle at $45.98 on Thursday. <a href="https://www.benzinga.com/quote/IBTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Bill Carcache upgraded the rating for Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) from Peer Perform to Outperform and announces $43 price target. Fifth Third Bancorp shares rose 1.4% to settle at $36.75 on Thursday. See how other analysts view this stock. <a href="https://www.benzinga.com/quote/FITB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods analyst Damon Delmonte upgraded Heartland Financial USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) from Market Perform to Outperform and boosted the price target from $51 to $54. Heartland Financial shares rose 2.6% to close at $43.07 on Thursday. <a href="https://www.benzinga.com/quote/HTLF/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Thomas Palmer upgraded the rating for Hormel Foods Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRL#NYSE">HRL</a>) from Underweight to Neutral, while raising the price target from $28 to $29. Hormel Foods shares fell 9.7% to settle at $30.79 on Thursday. <a href="https://www.benzinga.com/quote/HRL/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/05/39109738/how-to-earn-500-a-month-from-pfizer-stock">How To Earn $500 A Month From Pfizer Stock</a>

Upgrades

Analyst Ratings

ASAN

FITB

This Hormel Foods Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

Keefe, Bruyette &amp; Woods analyst Damon Delmonte upgrades Heartland Financial USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) from Market Perform to Outperform and raises the price target from $51 to $54.

Price Target

Keefe, Bruyette & Woods Upgrades Heartland Financial USA to Outperform, Raises Price Target to $54

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) has got to make money and is losing money. &#8220;It's been around forever, and it's not making money. That's <a href="https://www.benzinga.com/news/24/04/38181349/why-soundhound-ai-stock-is-moving-lower-wednesday">no good for me,&#8221; he added.</a>
SoundHound AI is expected to report its 2024 first quarter financial results on Thursday, May 9, after the closing bell.
&#8220;It's a little bit riskier than people would like,&#8221; Cramer said when asked about OneMain Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>). &#8220;It's a personal loaner. But, you know what, I think the Fed is going to lower rates, so I think it's going to work for you.&#8221;
On April 20, OneMain Holdings posted better-than-expected earnings for its first quarter and raised its dividend from $1.00 to $1.04 per share.
The &#8220;Mad Money&#8221; host said he is going to do some work on Cracker Barrel Old Country Store, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>). &#8220;I used to recommend this stock, and it has been horrendous, and I haven't looked at it in may years. So we'll come back and do that one,&#8221; he added.
Cracker Barrel is scheduled to provide a real-time webcast and rebroadcast of its strategic transformation plan update on Thursday, May 16.
Cramer said he likes General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) very much and recommended buying the same.
Goldman Sachs Group is reportedly in discussions to shift its General Motors credit-card program to Barclays, marking a huge move in Goldman's <a href="https://www.benzinga.com/markets/equities/24/04/38517046/goldman-sachs-mulls-gm-credit-card-program-shift-to-barclays-report">withdrawal from consumer lending</a>.
Heartland Financial USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) is a &#8220;very good&#8221; regional bank, Cramer said. &#8220;I think you're in good hands with that one.&#8221;
On April 29, UMB announced an agreement to acquire Heartland Financial.
Cramer said NextEra Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) is losing too much money for him to recommend.
On April 23, NextEra Energy posted better-than-expected quarterly earnings.
Price Action:
<ul>
<li>OneMain shares rose 0.1% to settle at $50.81 on Thursday.</li>
<li>SoundHound shares gained 1.8% to close at $4.49.</li>
<li>NextEra Energy shares gained 0.4% to settle at $68.85.</li>
<li>Cracker Barrel shares rose 1.5% to close at $57.18 on Thursday.</li>
<li>General Motors shares rose 0.5% to settle at $44.67 on Thursday.</li>
<li>Heartland Financial shares rose 2.8% to settle at $43.26 during Thursday's session.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38583147/around-2m-bet-on-citi-trends-check-out-these-3-stocks-insiders-are-buying">Around $2M Bet On Citi Trends? Check Out These 3 Stocks Insiders Are Buying</a>
Photo: Shutterstock

Media

CBRL

SOUN

Jim Cramer Says 'You're In Good Hands' With This 'Very Good' Regional Bank, Likes General Motors

DA Davidson analyst Jeff Rulis maintains Heartland Financial USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) with a Neutral and raises the price target from $36 to $45.

DA Davidson Maintains Neutral on Heartland Financial USA, Raises Price Target to $45

Keefe, Bruyette &amp; Woods analyst Damon Delmonte maintains Heartland Financial USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) with a Market Perform and raises the price target from $41 to $51.

Keefe, Bruyette & Woods Maintains Market Perform on Heartland Financial USA, Raises Price Target to $51

Shares of Clever Leaves Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLVR#NASDAQ">CLVR</a>) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister its Securities to terminate and suspend its reporting obligations.
Clever Leaves Holdings shares dipped 60% to $1.6498 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Deciphera Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCPH#NASDAQ">DCPH</a>) shares climbed 73% to $25.36 after the company announced it will be acquired by ONO Pharmaceutical for $25.60 per share in cash.</li>
<li>Collective Audience, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAUD#NASDAQ">CAUD</a>) gained 50.4% to $0.6002 after the company announced a strategic partnership with Insticator.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) shares gained 36.3% to $10.02. ImmunityBio shares jumped around 44% on Friday after the company announced overall survival results in its QUILT 3.055 study.</li>
<li>Koninklijke Philips N.V.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares climbed 35.5% to $28.56 after the company announced $1.1 billion settlement for Respironics personal injury and medical monitoring litigation. The company also reported better than expected first-quarter earnings and reaffirmed guidance.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) gained 31.1% to $49.66 after the company announced it received Breakthrough Therapy Designation from the FDA for DCCR extended-release tablets in Prader-Willi Syndrome.</li>
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) gained 25% to $3.9414 after the company announced the California Air Resources Board has approved the 2024 Mullen THREE for the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project.</li>
<li>Enlivex Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLV#NASDAQ">ENLV</a>) climbed 25% to $1.7990.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) rose 23.9% to $6.06 after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer&#8217;s Disease.</li>
<li>HWH International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) gained 23.8% to $2.25. HWH International recently announced that it entered into a joint venture to build its travel business in Asia.</li>
<li>Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSSE#NASDAQ">CSSE</a>) jumped 22% to $0.2948.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) rose 20.7% to $7.53.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) gained 19% to $1.0250.</li>
<li>Inno Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NASDAQ">INHD</a>) rose 17.8% to $0.7403.</li>
<li>Phibro Animal Health Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAHC#NASDAQ">PAHC</a>) gained 17.7% to $14.98. Zoetis announced plans to sell its medicated feed additive portfolio to Phibro Animal Health for $350 million.</li>
<li>Heartland Financial USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) gained 17.2% to $41.86 after UMB Financial announced it will acquire the company.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) rose 14.6% to $50.08.</li>
<li>Arcadium Lithium plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>) climbed 14.3% to $4.4350. Shares of lithium stocks traded higher, possibly on reports indicating Saudi Arabia is looking to obtain lithium from abroad for its EV efforts.</li>
<li>MultiPlan Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) gained 14% to $0.6566. MultiPlan said it will release its first quarter 2024 financial results on Wednesday, May 8.</li>
<li>Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) rose 11.2% to $4.9182 on FDA clearance of its IND application for PM359.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares gained 10.5% to $185.94 on reports the company will partner with Baidu for mapping and navigation for Full Self-Driving in China.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) rose 10.7% to $28.02. Cullinan Therapeutics announced appointment of Mary Kay Fenton as Chief Financial Officer.</li>
<li>Fulton Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) jumped 9.3% to $17.07. Republic First Bancorp has been seized by U.S. regulators and sold to Fulton Bank, a unit of Fulton Financial Corp.</li>
<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) gained 8.2% to $1.3850.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Annovis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NASDAQ">ANVS</a>) dipped 57% to $7.72 after the company announced data from its Phase II/III Alzheimer study of buntanetap in mild to moderate Alzheimer&#8217;s. Efficacy in the CGIC endpoint was not reached due to the limited number of patients and short trial duration.</li>
<li>Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) fell 48.8% to $8.25 after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.</li>
<li>mF International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFI#NASDAQ">MFI</a>) shares declined 30.3% to $1.6101 after dipping around 78% on Friday.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXI#NASDAQ">ATXI</a>) fell 21.8% to $4.8440 after the company announced the exercise of warrants for $4.4 million in gross proceeds.</li>
<li>China Jo-Jo Drugstores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJJD#NASDAQ">CJJD</a>) dipped 21% to $2.29 after the company announced a $1.53 million registered direct offering.</li>
<li>Assure Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONM#NASDAQ">IONM</a>) fell 19.5% to $0.56 after the company said the unaudited financial statements for the quarterly periods ended March 31, 2023, June 30, 2023 and Sept 30, 2023 should no longer be relied on.</li>
<li>iSun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISUN#NASDAQ">ISUN</a>) fell 19% to $0.1399. iSun, last week, announced rescission of reverse stock split.</li>
<li>Nature Wood Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWGL#NASDAQ">NWGL</a>) shares fell 18.8% to $4.10 after tumbling 70% on Friday.</li>
<li>Top KingWin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCJH#NASDAQ">TCJH</a>) fell 18% to $0.7301.</li>
<li>STRATA Skin Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSKN#NASDAQ">SSKN</a>) dipped 17.3% to $0.43. The company announced a 1-for-10 reverse stock split.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) fell 16.5% to $6.68.</li>
<li>Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>) declined 15.6% to $1.1492.</li>
<li>Lifezone Metals Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LZM#NYSE">LZM</a>) fell 15.3% to $7.00.</li>
<li>NuZee, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) shares fell 13.5% to $1.41 after jumping 34% on Friday.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) fell 10.4% to $3.0550. Wedbush analyst Alicia Reese reiterated AMC with a Neutral and maintained a $4 price target.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares declined 10.1% to $1.3493 after declining over 5% on Friday.</li>
<li>SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) fell 9.9% to $7.09 following first-quarter results.</li>
<li>Hope Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOPE#NASDAQ">HOPE</a>) dipped 9.7% to $9.90 after the company reported worse-than-expected first-quarter financial results and signed a definitive merger with Territorial Bancorp.</li>
<li>Daqo New Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) shares declined 9.3% to $21.55 after the company missed first-quarter EPS and sales estimates.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) fell 9.1% to $16.16 after the company disclosed it estimates it could have to pay up to €1.3 billion related to its Postbank litigation.</li>
<li>Altimmune, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) fell 9.4% to $6.58 after Guggenheim downgraded the stock from Buy to Neutral.</li>
<li>Calliditas Therapeutics AB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALT#NASDAQ">CALT</a>) fell 8.6% to $17.68.</li>
<li>Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) declined 8% to $2.7050.</li>
<li>Kyverna Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYTX#NASDAQ">KYTX</a>) dipped 7.5% to $14.31.</li>
<li>Civeo Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVEO#NYSE">CVEO</a>) fell 7% to $23.25.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38491128/nxp-semiconductors-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-ear">NXP Semiconductors Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Intraday Update

Movers

ADXN

ALTM

ANVS

APLD

ATXI

CALT

CAUD

CGEM

CJJD

CLVR

CSSE

CVEO

CYCC

DAVE

DCPH

ENLV

FLGC

FTEL

IBRX

INHD

IONM

ISUN

KYTX

MESO

MPLN

MULN

NUZE

NWGL

OCGN

PAHC

PRME

SLNO

SOFI

SSKN

TCJH

TSLA

ZVSA

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

UMB Financial Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) shares are trading lower after it inked an acquisition deal, priced an underwritten offering, and reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/b38485845/umb-financial-corporation-reports-first-quarter-2024-net-income-of-110-3-million-and-net-operating" rel="noreferrer noopener">first-quarter FY24 results</a>.
M&amp;A: The company inked a definitive merger&nbsp;deal to acquire&nbsp;Heartland Financial, USA Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) in an all-stock transaction valued at around $2.0 billion.
As per the terms, Heartland shareholders will receive a fixed exchange ratio of 0.55 shares of UMB common shares for each share of HTLF stock they hold.&nbsp;
The per-share&nbsp;price&nbsp;consideration&nbsp;is valued&nbsp;at $45.74 per share based on UMB&#8217;s closing price of $83.17 on April 26.&nbsp;
This transaction, the largest in UMB&#8217;s 111-year history, will result in the company having $64.5 billion in assets, increase private wealth management&#8217;s AUM/AUA by 31%&nbsp;and&nbsp;nearly double its retail deposit base.&nbsp;
The transaction is subject to customary closing conditions, including regulatory approvals and approval by UMB shareholders and HTLF stockholders, and&nbsp;is expected&nbsp;to close in the first quarter of 2025.
First-quarter Earnings: UMB Financial reported revenue of $398.7 million, beating the consensus of $368.0 million, and adjusted EPS of $2.47, surpassing <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">the consensus of $1.76</a>. 
The Board approved a share repurchase of up to 1 million shares and declared a quarterly cash dividend of $0.39 per share, payable on July 1, to shareholders of record on&nbsp;June 10.
Mariner Kemper, chairman&nbsp;and&nbsp;chief executive&nbsp;officer,&nbsp;said, &#8220;Our 2024 is off to a great start, with strong first quarter financial results driven by balance sheet and net interest income growth, net interest margin expansion, double-digit growth in our fee income revenue, and stable credit metrics.&#8221;&nbsp;
&#8220;While indications suggest the economy is on reasonably stable footing, persistently high inflation, an upcoming presidential election cycle, and a potential &#8216;No Landing&#8217; scenario may dictate a constrictive Federal Reserve monetary policy that could pose economic challenges.&#8221;
Public Offering Pricing: UMB Financial disclosed that it priced an underwritten public offering of 2.80 million shares of its common stock for around net <a href="https://www.benzinga.com/pressreleases/24/04/b38485887/umb-financial-corporation-announces-pricing-of-an-underwritten-offering-of-2-800-000-shares-of-com" target="_blank" rel="noreferrer noopener">proceeds of $201.6 million</a>.
Price Action: UMBF shares are down 4% at $79.83, while HTLF is up 19% at $42.54 at the last check Monday.
Photo via Shutterstock

Equities

Mid Cap

Offerings

UMB Financial Is Down After Largest Acquisition In Its 111-Year History - Here's Why

U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday.
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose sharply during Monday's session on reports the company will partner with Baidu for mapping and navigation for <a href="https://www.benzinga.com/markets/equities/24/04/38485399/tesla-skyrockets-about-10-in-premarket-whats-fueling-the-dramatic-rally">Full Self-Driving in China</a>.
Tesla shares jumped 10.5% to $185.94 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Deciphera Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCPH#NASDAQ">DCPH</a>) shares surged 73% to $25.36 after the company announced it will be acquired by ONO Pharmaceutical for $25.60 per share in cash.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) shares rose 36.3% to $10.02. ImmunityBio shares jumped around 44% on Friday after the company announced overall survival results in its QUILT 3.055 study.</li>
<li>Koninklijke Philips N.V.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares gained 35.5% to $28.56 after the company announced $1.1 billion settlement for Respironics personal injury and medical monitoring litigation. The company also reported better than expected first-quarter earnings and reaffirmed guidance.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) shares jumped 31.1% to $49.66 after the company announced it received Breakthrough Therapy Designation from the FDA for DCCR extended-release tablets in Prader-Willi Syndrome.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) gained 20.7% to $7.53.</li>
<li>MMTec, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) jumped 20% to $3.38.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) climbed 19% to $1.0250.</li>
<li>Phibro Animal Health Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAHC#NASDAQ">PAHC</a>) rose 17.7% to $14.98. Zoetis announced plans to sell its medicated feed additive portfolio to Phibro Animal Health for $350 million.</li>
<li>Heartland Financial USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLF#NASDAQ">HTLF</a>) rose 17.2% to $41.86 after UMB Financial announced it will acquire the company.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) gained 14.6% to $50.08.</li>
<li>Arcadium Lithium plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NASDAQ">ALTM</a>) rose 14.5% to $4.45.</li>
<li>MultiPlan Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) jumped 14% to $0.6566. MultiPlan said it will release its first quarter 2024 financial results on Wednesday, May 8.</li>
<li>Exscientia plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAI#NASDAQ">EXAI</a>) rose 12.7% to $4.5399.</li>
<li>Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) gained 11.2% to $4.9182 on FDA clearance of its IND application for PM359.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) climbed 10.7% to $28.02. Cullinan Therapeutics announced appointment of Mary Kay Fenton as Chief Financial Officer.</li>
<li>Fulton Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) gained 9.3% to $17.07. Republic First Bancorp has been seized by U.S. regulators and sold to Fulton Bank, a unit of Fulton Financial Corp.</li>
<li>Tellurian Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TELL#NYSE">TELL</a>) gained 7.7% to $0.5031.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) rose 7% to $36.07.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) rose 6.2% to $1.56.</li>
<li>Albemarle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) gained 6% to $123.86, possibly on reports indicating Saudi Arabia is looking to obtain lithium from abroad for its EV efforts.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) rose 5.7% to $37.21 after Wells Fargo upgraded the stock from Equal-Weight to Overweight and raised its price target from $21 to $45.</li>
<li>Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) rose 4.8% to $12.48  on reports of the Redstone family and David Ellison making concessions to investors, with Ellison reportedly proposing to purchase a block of shares at a premium.</li>
<li>GrafTech International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NASDAQ">EAF</a>) gained 4.4% to $1.65.        </li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) rose 4.1% to $58.65. Seaport Global analyst David Joyce upgraded Roku from Neutral to Buy and announced a $74 price target.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/04/38489087/jim-cramer-likes-palantir-recommends-pioneer-natural-resources-i-want-you-to-ka-ching-ka-ching">Jim Cramer Likes Palantir, Recommends Pioneer Natural Resources: &#8216;I Want You To Ka-Ching, Ka-Ching&#8217;</a>

EXAI

PACB

PARA

ROKU

TELL

TNDM

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday

Comments

Heartland Financial USA

Notizie

Ultime notizie per Heartland Financial USA (NASDAQ:HTLF) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO